Dr. Reddy’s receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India

A nurse shows Russia’s ‘Sputnik-V’ vaccine against the coronavirus disease (COVID-19) prepared for inoculation in a post-registration trials stage at a clinic in Moscow (reuters) India, January 15, 2021: Dr. Reddy’s Laboratories Ltd announced today that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the Sputnik V vaccine in India. The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India. Earlier, the Data and Safety…